Mediators of immune response, cell adhesion, cell growth, cell death, intercellular signaling, and metabolism were all up-regulated in LRRC3B-expressing xenograft tumor models, and showed higher immune scores of activated CD4 T cells, and activated CD8. Here, CD8A is linked to neoplasm.